Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)-Reference-Cited by-同舟云学术

Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)

Published:2013-12 Issue:12 Volume:44 Page:2711-2718
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Houang Michelle,Clarkson Adele,Sioson Loretta,Elston Marianne S.,Clifton-Bligh Roderick J.,Dray Michael,Ranchere-Vince Dominique,Decouvelaere Anne-Valerie,de la Fouchardiere Arnaud,Gill Anthony J.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference24 articles.

1. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature;Folpe;Am J Surg Pathol,2004

2. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia;Jonsson;N Engl J Med,2003

3. Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia;Larsson;Eur J Endocrinol,2003

4. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia;Nelson;J Clin Endocrinol Metab,2003

5. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization;Quarles;Am J Physiol Endocrinol Metab,2003

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracranial Phosphaturic Mesenchymal Tumors: A Systematic Literature Review of a Rare Entity;World Neurosurgery;2024-07

2. Challenges in the diagnosis and management of tumor-induced osteomalacia: A case report;Heliyon;2024-06

3. Emerging Role of Gallium-68 DOTANOC PET/CT Guided Radiofrequency Ablation in the Treatment of Tumor-induced Osteomalacia;JCEM Case Reports;2024-04-23

4. Prolonged generalized osteomalacia associated with a sinonasal cavity phosphaturic mesenchymal tumor: A case report;Clinical Case Reports;2024-01-30

5. Rare Tumours of Bone;Bone Tumors;2024